PSA-IgM and iXip in the diagnosis and management of prostate cancer: clinical relevance and future potential. A review.

The Prostate Specific Antigen (PSA) is the first filter in the diagnosis of prostate cancer. Unfortunately, it is organ-specific but not cancer-specific. In addition, some prostate cancers are not clinically-significant and their diagnosis and treatment may lead to overdiagnosis and overtreatment. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Maestroni, Umberto, Cavalieri, Domenico, Campobasso, Davide, Guarino, Giulio, Ziglioli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823593/
https://www.ncbi.nlm.nih.gov/pubmed/35075069
http://dx.doi.org/10.23750/abm.v92i6.12058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823593/
https://www.ncbi.nlm.nih.gov/pubmed/35075069
http://dx.doi.org/10.23750/abm.v92i6.12058

Ejemplares similares